Aptyx, a global leader in life sciences manufacturing, has acquired Medical Murray’s Charlotte, NC, facility, a hub for ...

Aptyx acquired the Charlotte, North Carolina facility of Medical Murray, which develops and produces catheter-based ...

Cardiac device innovations made waves in 2024, with regulatory approvals, clinical breakthroughs, and product launches ...

Conclusions: With the use of recommended implant techniques, the study results support the electrical efficacy and safety of a catheter-delivered, lumenless lead in traditional or alternate right ...

"Catheter ablation and antiarrhythmic drug therapy can reduce the risk of recurrent ventricular tachycardia and implantable cardioverter-defibrillator shock, but both approaches are associated ...

Central venous catheter-related blood stream infection (CRBSI) is a major cause of morbidity and mortality in patients with end-stage renal disease treated with chronic hemodialysis. Risk factors ...

The initial multi-center study results of the first right heart catheter-delivered lumenless lead demonstrate feasibility of the implant technique and acceptable electrical performance through 18 ...